{"transactions":[{"id":912282,"issuer":{"id":7588,"kind":"organization","name":"Jasper Therapeutics, Inc."},"owners":[{"id":67062,"kind":"person","name":"Mahal Jeetinder Singh","position":1,"cik":"0001882877","reported_name":"Mahal Jeetinder Singh","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Stock Option (right to buy)","published_at":"2026-02-10T16:00:23.000Z","date":"2026-02-06","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares subject to the option shall vest on February 6, 2027, and 1/48th of the original number of shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive."}],"balance_after":500000,"derivative":{"exercise_price":1.35,"expiration_date":"2036-02-06","underlying":"Voting Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001213900-26-014244","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1882877/000121390026014244/ownership.xml","form_type":"4"}},{"id":952030,"issuer":{"id":7588,"kind":"organization","name":"Jasper Therapeutics, Inc."},"owners":[{"id":67062,"kind":"person","name":"Mahal Jeetinder Singh","position":1,"cik":"0001882877","reported_name":"Mahal Jeetinder Singh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-01-05T19:30:34.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares subject to the option shall vest on January 2, 2027, and 1/48th of the original number of shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive."}],"balance_after":90000,"derivative":{"exercise_price":1.84,"expiration_date":"2036-01-02","underlying":"Voting Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001213900-26-001383","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1882877/000121390026001383/ownership.xml","form_type":"4"}},{"id":1119932,"issuer":{"id":7588,"kind":"organization","name":"Jasper Therapeutics, Inc."},"owners":[{"id":67062,"kind":"person","name":"Mahal Jeetinder Singh","position":1,"cik":"0001882877","reported_name":"Mahal Jeetinder Singh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-06-06T06:27:57.000Z","date":"2025-06-04","kind":"grant","planned":false,"acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares subject to the retention option shall vest on June 4, 2026 and 1/48th of the shares subject to the retention option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive."}],"balance_after":90000,"derivative":{"exercise_price":6,"expiration_date":"2035-06-04","underlying":"Voting Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001213900-25-051726","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1882877/000121390025051726/ownership.xml","form_type":"4"}},{"id":1264058,"issuer":{"id":7588,"kind":"organization","name":"Jasper Therapeutics, Inc."},"owners":[{"id":67062,"kind":"person","name":"Mahal Jeetinder Singh","position":1,"cik":"0001882877","reported_name":"Mahal Jeetinder Singh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-02-18T17:31:26.000Z","date":"2025-02-13","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares subject to the option shall vest on February 13, 2026, and 1/48th of the original number of shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive."}],"balance_after":50000,"derivative":{"exercise_price":6.2,"expiration_date":"2035-02-13","underlying":"Voting Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001213900-25-014951","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1882877/000121390025014951/ownership.xml","form_type":"4"}},{"id":1334165,"issuer":{"id":7588,"kind":"organization","name":"Jasper Therapeutics, Inc."},"owners":[{"id":67062,"kind":"person","name":"Mahal Jeetinder Singh","position":1,"cik":"0001882877","reported_name":"Mahal Jeetinder Singh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-12-12T20:02:41.000Z","date":"2024-12-12","kind":"exercise","planned":true,"acquired":true,"shares":900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the original number of shares subject to the option vested on December 12, 2020, and 1/48th of the original number of shares subject to the option vested monthly thereafter."}],"balance_after":13772,"derivative":{"exercise_price":7.1,"expiration_date":"2030-05-31","underlying":"Voting Common Stock","underlying_shares":900},"source":{"system":"sec-edgar","filing":"0001213900-24-108551","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1882877/000121390024108551/ownership.xml","form_type":"4"}},{"id":1334164,"issuer":{"id":7588,"kind":"organization","name":"Jasper Therapeutics, Inc."},"owners":[{"id":67062,"kind":"person","name":"Mahal Jeetinder Singh","position":1,"cik":"0001882877","reported_name":"Mahal Jeetinder Singh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Voting Common Stock","published_at":"2024-12-12T20:02:41.000Z","date":"2024-12-12","kind":"sale","planned":true,"acquired":false,"shares":900,"price":22.11,"value":19899.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2023."}],"balance_after":25009,"source":{"system":"sec-edgar","filing":"0001213900-24-108551","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1882877/000121390024108551/ownership.xml","form_type":"4"}},{"id":1334163,"issuer":{"id":7588,"kind":"organization","name":"Jasper Therapeutics, Inc."},"owners":[{"id":67062,"kind":"person","name":"Mahal Jeetinder Singh","position":1,"cik":"0001882877","reported_name":"Mahal Jeetinder Singh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Voting Common Stock","published_at":"2024-12-12T20:02:41.000Z","date":"2024-12-12","kind":"exercise","planned":true,"acquired":true,"shares":900,"price":7.1,"value":6390.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2023."}],"balance_after":25909,"source":{"system":"sec-edgar","filing":"0001213900-24-108551","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1882877/000121390024108551/ownership.xml","form_type":"4"}},{"id":1408814,"issuer":{"id":7588,"kind":"organization","name":"Jasper Therapeutics, Inc."},"owners":[{"id":67062,"kind":"person","name":"Mahal Jeetinder Singh","position":1,"cik":"0001882877","reported_name":"Mahal Jeetinder Singh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-09-12T17:19:07.000Z","date":"2024-09-12","kind":"exercise","planned":true,"acquired":true,"shares":900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the original number of shares subject to the option vested on December 12, 2020, and 1/48th of the original number of shares subject to the option vested monthly thereafter."}],"balance_after":14672,"derivative":{"exercise_price":7.1,"expiration_date":"2030-05-31","underlying":"Voting Common Stock","underlying_shares":900},"source":{"system":"sec-edgar","filing":"0001213900-24-078214","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1882877/000121390024078214/ownership.xml","form_type":"4"}},{"id":1408813,"issuer":{"id":7588,"kind":"organization","name":"Jasper Therapeutics, Inc."},"owners":[{"id":67062,"kind":"person","name":"Mahal Jeetinder Singh","position":1,"cik":"0001882877","reported_name":"Mahal Jeetinder Singh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Voting Common Stock","published_at":"2024-09-12T17:19:07.000Z","date":"2024-09-12","kind":"sale","planned":true,"acquired":false,"shares":900,"price":21.2263,"value":19103.67,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.795 to $21.495, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price."}],"balance_after":25009,"source":{"system":"sec-edgar","filing":"0001213900-24-078214","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1882877/000121390024078214/ownership.xml","form_type":"4"}},{"id":1408812,"issuer":{"id":7588,"kind":"organization","name":"Jasper Therapeutics, Inc."},"owners":[{"id":67062,"kind":"person","name":"Mahal Jeetinder Singh","position":1,"cik":"0001882877","reported_name":"Mahal Jeetinder Singh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Voting Common Stock","published_at":"2024-09-12T17:19:07.000Z","date":"2024-09-12","kind":"exercise","planned":true,"acquired":true,"shares":900,"price":7.1,"value":6390.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2023."}],"balance_after":25909,"source":{"system":"sec-edgar","filing":"0001213900-24-078214","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1882877/000121390024078214/ownership.xml","form_type":"4"}},{"id":1482284,"issuer":{"id":7588,"kind":"organization","name":"Jasper Therapeutics, Inc."},"owners":[{"id":67062,"kind":"person","name":"Mahal Jeetinder Singh","position":1,"cik":"0001882877","reported_name":"Mahal Jeetinder Singh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-06-12T21:40:02.000Z","date":"2024-06-12","kind":"exercise","planned":true,"acquired":true,"shares":900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the original number of shares subject to the option vested on December 12, 2020, and 1/48th of the original number of shares subject to the option vested monthly thereafter."}],"balance_after":15572,"derivative":{"exercise_price":7.1,"expiration_date":"2030-05-31","underlying":"Voting Common Stock","underlying_shares":900},"source":{"system":"sec-edgar","filing":"0001213900-24-052215","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1882877/000121390024052215/ownership.xml","form_type":"4"}},{"id":1482283,"issuer":{"id":7588,"kind":"organization","name":"Jasper Therapeutics, Inc."},"owners":[{"id":67062,"kind":"person","name":"Mahal Jeetinder Singh","position":1,"cik":"0001882877","reported_name":"Mahal Jeetinder Singh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Voting Common Stock","published_at":"2024-06-12T21:40:02.000Z","date":"2024-06-12","kind":"sale","planned":true,"acquired":false,"shares":900,"price":24.155,"value":21739.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.975 to $24.555, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price."}],"balance_after":25009,"source":{"system":"sec-edgar","filing":"0001213900-24-052215","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1882877/000121390024052215/ownership.xml","form_type":"4"}},{"id":1482282,"issuer":{"id":7588,"kind":"organization","name":"Jasper Therapeutics, Inc."},"owners":[{"id":67062,"kind":"person","name":"Mahal Jeetinder Singh","position":1,"cik":"0001882877","reported_name":"Mahal Jeetinder Singh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Voting Common Stock","published_at":"2024-06-12T21:40:02.000Z","date":"2024-06-12","kind":"exercise","planned":true,"acquired":true,"shares":900,"price":7.1,"value":6390.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2023."}],"balance_after":25909,"source":{"system":"sec-edgar","filing":"0001213900-24-052215","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1882877/000121390024052215/ownership.xml","form_type":"4"}},{"id":1581681,"issuer":{"id":7588,"kind":"organization","name":"Jasper Therapeutics, Inc."},"owners":[{"id":67062,"kind":"person","name":"Mahal Jeetinder Singh","position":1,"cik":"0001882877","reported_name":"Mahal Jeetinder Singh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-03-12T21:33:11.000Z","date":"2024-03-12","kind":"exercise","planned":false,"acquired":true,"shares":900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The exercise price of the option and number of shares subject to the option were adjusted as a result of the Reverse Split, and numbers reported herein reflect the exercise price and number of shares subject to the option after the Reverse Split."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"25% of the original number of shares subject to the option vested on December 12, 2020, and 1/48th of the original number of shares subject to the option vested monthly thereafter."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The exercise price of the option and number of shares subject to the option were adjusted as a result of the Reverse Split, and numbers reported herein reflect the exercise price and number of shares subject to the option after the Reverse Split."}],"balance_after":16472,"derivative":{"exercise_price":7.1,"expiration_date":"2030-05-31","underlying":"Voting Common Stock","underlying_shares":900},"source":{"system":"sec-edgar","filing":"0001213900-24-021961","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1882877/000121390024021961/ownership.xml","form_type":"4"}},{"id":1581680,"issuer":{"id":7588,"kind":"organization","name":"Jasper Therapeutics, Inc."},"owners":[{"id":67062,"kind":"person","name":"Mahal Jeetinder Singh","position":1,"cik":"0001882877","reported_name":"Mahal Jeetinder Singh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Voting Common Stock","published_at":"2024-03-12T21:33:11.000Z","date":"2024-03-12","kind":"sale","planned":false,"acquired":false,"shares":900,"price":26.4358,"value":23792.22,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.14 to $26.79, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price."}],"balance_after":25009,"source":{"system":"sec-edgar","filing":"0001213900-24-021961","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1882877/000121390024021961/ownership.xml","form_type":"4"}},{"id":1581679,"issuer":{"id":7588,"kind":"organization","name":"Jasper Therapeutics, Inc."},"owners":[{"id":67062,"kind":"person","name":"Mahal Jeetinder Singh","position":1,"cik":"0001882877","reported_name":"Mahal Jeetinder Singh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Voting Common Stock","published_at":"2024-03-12T21:33:11.000Z","date":"2024-03-12","kind":"exercise","planned":false,"acquired":true,"shares":900,"price":7.1,"value":6390.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Effective on January 4, 2024, the Issuer conducted a reverse stock split of its voting common stock at a ratio of 1-for-10 (the \"Reverse Split\"). The number of shares reported herein reflects the number of shares after the Reverse Split."}],"balance_after":25909,"source":{"system":"sec-edgar","filing":"0001213900-24-021961","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1882877/000121390024021961/ownership.xml","form_type":"4"}},{"id":1634275,"issuer":{"id":7588,"kind":"organization","name":"Jasper Therapeutics, Inc."},"owners":[{"id":67062,"kind":"person","name":"Mahal Jeetinder Singh","position":1,"cik":"0001882877","reported_name":"Mahal Jeetinder Singh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-02-20T19:31:13.000Z","date":"2024-02-15","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares subject to the option shall vest on February 15, 2025, and 1/48th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive."}],"balance_after":40000,"derivative":{"exercise_price":17.95,"expiration_date":"2034-02-15","underlying":"Voting Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001213900-24-015462","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1882877/000121390024015462/ownership.xml","form_type":"4"}},{"id":1760664,"issuer":{"id":7588,"kind":"organization","name":"Jasper Therapeutics, Inc."},"owners":[{"id":67062,"kind":"person","name":"Mahal Jeetinder Singh","position":1,"cik":"0001882877","reported_name":"Mahal Jeetinder Singh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Voting Common Stock","published_at":"2023-10-13T18:58:59.000Z","date":"2023-10-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":37126,"price":0.85,"value":31557.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares of the Issuer's common stock upon the vesting of restricted stock units."}],"balance_after":250097,"source":{"system":"sec-edgar","filing":"0001013762-23-003903","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1882877/000101376223003903/ownership.xml","form_type":"4"}},{"id":1857453,"issuer":{"id":7588,"kind":"organization","name":"Jasper Therapeutics, Inc."},"owners":[{"id":67062,"kind":"person","name":"Mahal Jeetinder Singh","position":1,"cik":"0001882877","reported_name":"Mahal Jeetinder Singh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2023-06-13T20:54:21.000Z","date":"2023-06-13","kind":"exercise","planned":true,"acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the original number of shares subject to the option vested on December 12, 2020, and 1/48th of the original number of shares have vested and shall vest monthly thereafter, subject to the Reporting Person's continued service to the Issuer through each such vesting date."}],"balance_after":173713,"derivative":{"exercise_price":0.71,"expiration_date":"2030-05-31","underlying":"Voting Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001213900-23-048683","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1882877/000121390023048683/ownership.xml","form_type":"4"}},{"id":1857452,"issuer":{"id":7588,"kind":"organization","name":"Jasper Therapeutics, Inc."},"owners":[{"id":67062,"kind":"person","name":"Mahal Jeetinder Singh","position":1,"cik":"0001882877","reported_name":"Mahal Jeetinder Singh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Voting Common Stock","published_at":"2023-06-13T20:54:21.000Z","date":"2023-06-13","kind":"sale","planned":true,"acquired":false,"shares":9000,"price":1.6572,"value":14914.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.62 to $1.69, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price."}],"balance_after":287223,"source":{"system":"sec-edgar","filing":"0001213900-23-048683","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1882877/000121390023048683/ownership.xml","form_type":"4"}},{"id":1857451,"issuer":{"id":7588,"kind":"organization","name":"Jasper Therapeutics, Inc."},"owners":[{"id":67062,"kind":"person","name":"Mahal Jeetinder Singh","position":1,"cik":"0001882877","reported_name":"Mahal Jeetinder Singh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Voting Common Stock","published_at":"2023-06-13T20:54:21.000Z","date":"2023-06-13","kind":"exercise","planned":true,"acquired":true,"shares":9000,"price":0.71,"value":6390.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2023."}],"balance_after":296223,"source":{"system":"sec-edgar","filing":"0001213900-23-048683","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1882877/000121390023048683/ownership.xml","form_type":"4"}},{"id":1919720,"issuer":{"id":7588,"kind":"organization","name":"Jasper Therapeutics, Inc."},"owners":[{"id":67062,"kind":"person","name":"Mahal Jeetinder Singh","position":1,"cik":"0001882877","reported_name":"Mahal Jeetinder Singh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Voting Common Stock","published_at":"2023-04-14T16:16:34.000Z","date":"2023-04-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":37126,"price":1.46,"value":54203.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares of the Issuer's common stock upon the vesting of restricted stock units."}],"balance_after":287223,"source":{"system":"sec-edgar","filing":"0001213900-23-029893","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1882877/000121390023029893/ownership.xml","form_type":"4"}},{"id":1944783,"issuer":{"id":7588,"kind":"organization","name":"Jasper Therapeutics, Inc."},"owners":[{"id":67062,"kind":"person","name":"Mahal Jeetinder Singh","position":1,"cik":"0001882877","reported_name":"Mahal Jeetinder Singh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2023-03-20T18:00:57.000Z","date":"2023-03-17","kind":"grant","planned":false,"acquired":true,"shares":350000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares subject to the option shall vest on March 3, 2024, and 1/48th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive."}],"balance_after":350000,"derivative":{"exercise_price":1.87,"expiration_date":"2033-03-17","underlying":"Voting Common Stock","underlying_shares":350000},"source":{"system":"sec-edgar","filing":"0001213900-23-021494","document":"marketforms-60959.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1882877/000121390023021494/marketforms-60959.xml","form_type":"4"}},{"id":2137785,"issuer":{"id":7588,"kind":"organization","name":"Jasper Therapeutics, Inc."},"owners":[{"id":67062,"kind":"person","name":"Mahal Jeetinder Singh","position":1,"cik":"0001882877","reported_name":"Mahal Jeetinder Singh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Voting Common Stock","published_at":"2022-10-13T20:02:20.000Z","date":"2022-10-12","kind":"grant","acquired":true,"shares":214722,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are represented by restricted stock units, 1/2 of which shall vest on each of April 12, 2023 and October 12, 2023, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive."}],"balance_after":324349,"source":{"system":"sec-edgar","filing":"0001213900-22-063941","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1882877/000121390022063941/ownership.xml","form_type":"4"}},{"id":2300506,"issuer":{"id":7588,"kind":"organization","name":"Jasper Therapeutics, Inc."},"owners":[{"id":67062,"kind":"person","name":"Mahal Jeetinder Singh","position":1,"cik":"0001882877","reported_name":"Mahal Jeetinder Singh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2022-04-08T16:01:31.000Z","date":"2022-04-07","kind":"grant","acquired":true,"shares":48441,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares subject to the option shall vest on March 21, 2023, and 1/48th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive."}],"balance_after":48441,"derivative":{"exercise_price":3.12,"expiration_date":"2032-04-07","underlying":"Voting Common Stock","underlying_shares":48441},"source":{"system":"sec-edgar","filing":"0001213900-22-018928","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1882877/000121390022018928/ownership.xml","form_type":"4"}},{"id":2320244,"issuer":{"id":7588,"kind":"organization","name":"Jasper Therapeutics, Inc."},"owners":[{"id":67062,"kind":"person","name":"Mahal Jeetinder Singh","position":1,"cik":"0001882877","reported_name":"Mahal Jeetinder Singh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO,CFO and CS"}}],"security":"Stock Option (right to buy)","published_at":"2022-03-23T18:02:26.000Z","date":"2022-03-21","kind":"grant","acquired":true,"shares":87272,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4th of the shares subject to the option shall vest on March 21, 2023, and 1/48th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive."}],"balance_after":87272,"derivative":{"exercise_price":3.54,"expiration_date":"2032-03-21","underlying":"Voting Common Stock","underlying_shares":87272},"source":{"system":"sec-edgar","filing":"0001213900-22-014565","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1882877/000121390022014565/ownership.xml","form_type":"4"}},{"id":2320243,"issuer":{"id":7588,"kind":"organization","name":"Jasper Therapeutics, Inc."},"owners":[{"id":67062,"kind":"person","name":"Mahal Jeetinder Singh","position":1,"cik":"0001882877","reported_name":"Mahal Jeetinder Singh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO,CFO and CS"}}],"security":"Stock Option (right to buy)","published_at":"2022-03-23T18:02:26.000Z","date":"2022-03-21","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares subject to the option shall vest on December 7, 2022, and 1/48th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive."}],"balance_after":7500,"derivative":{"exercise_price":3.54,"expiration_date":"2032-03-21","underlying":"Voting Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001213900-22-014565","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1882877/000121390022014565/ownership.xml","form_type":"4"}}]}